Physician profile
Nehal Ninad
NPI 1639708654
$3,624.72
in general payments reported to CMS, 2019-2025
22 companies · $565 in 2025
The $565 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $29.88 · 2021: $141 · 2022: $703 · 2023: $1,134 · 2024: $1,052 · 2025: $565.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,750.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $1,359.45 | 2022-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Depuy Synthes Sales INC. | $869.36 | 2021-2025 | Matrixrib |
| Davol INC. | $294.85 | 2024-2025 | Phasix Mesh |
| Allergan, INC. | $225.20 | 2021-2022 | |
| Kerecis Limited | $216.32 | 2022-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Aroa Biosurgery Incorporated | $189.71 | 2022-2024 | |
| W. L. Gore & Associates, INC. | $81.71 | 2024 | Gore-Tex Stretch Vascular Graft |
| Ethicon US, LLC | $57.93 | 2023 | Echelon Flex, Harmonic, Surgicel Nu-Knit |
| Haemonetics Corporation | $44.52 | 2023 | Teg5000 Hemostasis Analyzer |
| Becton, Dickinson and Company | $39.48 | 2025 | Hemosphere |
| Baxter Healthcare | $33.17 | 2023 | Seprafilm, Floseal |
| Avanos Medical | $29.88 | 2020 | |
| Biocomposites INC | $26.38 | 2023 | Stimulan |
| Astrazeneca Pharmaceuticals LP | $20.48 | 2023 | Andexxa |
| Lifenet Health | $20.13 | 2024 | Theragenesis Wound Matrix |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $19.92 | 2024 | Lynparza, Keytruda |
| Teleflex LLC | $18.25 | 2025 | Quikclot |
| Innovation Technologies INC | $18.14 | 2023 | Irrisept |
| Csl Behring | $17.79 | 2021 | |
| La Jolla Pharmaceutical Company | $16.85 | 2023 | Giapreza |
| Kci USA, INC. | $12.93 | 2022 | |
| Janssen Pharmaceuticals, INC | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nehal Ninad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.